mjellis

Matthew J. Ellis, MB., BChir., Ph.D., FRCP

Picture

matthew.ellis@bcm.edu

Faculty: Lester and Sue Smith Breast Center - Administrative
Baylor College of Medicine
Houston, TX US

PhD from University of London: 05/1992 - London, United Kingdom; Molecular Biology

Fellowship at Georgetown University Hospital: 06/1994 - Washington, District of Columbia United States; Medical Oncology

Residency at Royal College of Physicians: 06/1988 - London, United Kingdom; Medicine

"Activating HER2 mutations in HER2 gene amplification negative breast cancer." Cancer discovery. 2013;3(2):224-37. 2013;
"Whole-genome analysis informs breast cancer response to aromatase inhibition." Nature. 2012;486(7403):353-60.. 2012;
"Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium." Cancer discovery. 2013;3(10):1108-12. 2012;
"The genomic landscape of breast cancer as a therapeutic roadmap." Cancer discovery. 2013;3(1):27-34. 2013;

"New concepts in breast cancer genomics and genetics.." Breast cancer research : BCR. 2014;16(5):460.. 2014;
"Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts." Cell reports. 2013;4(6):1116-30. 2013;
"Incorporating genomics into breast cancer clinical trials and care." Clinical cancer research: an official journal. 2013;
Li Ding, Amanda G Paulovich, David Fenyö, Matthew J Ellis, Steven A Carr, "Proteogenomics connects somatic mutations to signalling in breast cancer." 2016 Jun 2;534(7605):55-62. Pubmed PMID: 27251275
Sherri R Davies, Kelly Hunt, Vera J Suman, Jacqueline Snider, Thomas Walsh, Graham A Colditz, Katherine DeSchryver, Richard K Wilson, Elaine R Mardis, Matthew J Ellis "Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers." 2016 Aug 9;7 Pubmed PMID: 27502118